RBCC Explores New Cures for Cancer, Brain Injuries & Headaches
News Jan 31, 2012
Cutting-edge stem cell research is producing new breakthroughs that could potentially revolutionize the treatment of currently incurable diseases from cancer to brain injuries to headaches.
As the world’s population ages and the economic might of emerging countries such as China and India blossoms, the market is increasing daily for new and effective cures to old ailments. RBCC plans to capitalize on recent growth in the biosciences sector by commercializing advanced-stage research with the potential to produce new treatments.
RBCC is aiming high. The company’s current target, n3D Biosciences, has developed a breakthrough cell-culturing system that allows scientists to grow 3D stem cells that behave much more similarly to cells found in the body. This product may directly assist with advanced discoveries to find cures for common injuries and diseases.
With the help of its new allies in BioHouston, RBCC plans to identify new targets on the cutting-edge of biotechnology for acquisition and joint venture.
Innate Reaction of Hematopoietic Stem Cells to Severe InfectionsNews
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018
EMBL Course: Techniques for Mammary Gland Research
Mar 05 - Mar 09, 2018